SCLERIFUMA 240 (Dimethyl fumarate (240mg))

Sclerifuma 240 Capsule is prescribed for the management of multiple sclerosis (MS), a condition characterized by the deterioration of nerve fibers due to inflammation and immune responses. This medication functions by inhibiting the immune system’s activity that contributes to nerve damage, thereby assisting in the stabilization of the disease and minimizing further progression. It is important to note that Sclerifuma 240 is not a definitive treatment for MS and does not provide a cure. Patients should adhere to their physician’s instructions regarding dosage and administration. Taking the capsule with meals may help prevent gastrointestinal discomfort. Regular monitoring through blood and urine tests may be necessary to assess blood cell counts and evaluate kidney and liver performance during treatment. To maximize the effectiveness of this medication, it should be taken consistently at the same time each day, and one should not discontinue use without consulting a healthcare provider. Some individuals may experience side effects including flushing, abdominal discomfort, diarrhea, nausea, vomiting, indigestion, gastritis, elevated liver enzymes, and skin rashes. If any of these effects persist or escalate, patients should promptly inform their healthcare provider for potential management strategies. Prior to commencing treatment, it is essential to disclose any existing health conditions, such as low white blood cell counts or infections, as well as all other medications being taken to ensure safe use. It is advisable for pregnant or breastfeeding women to seek medical guidance before starting this medication, as it may pose risks to the unborn or nursing infant.